Levitt Daniel J

EVP and Chief Medical Officer

Avg. Two Year Performance

163% Avg. Purchase Return    62% Compound
No Sale Track Record

Holdings: 214.29K shares

Last Three Months: 24-Feb-22 -- 23-May-22

0 Net Amount
Buy:0--
Sell:0--

Sentiment

Insider Trading Sentiment: Hold

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment:
Insider Trading Sentiment:
Insider Trading Sentiment:

Two Year Chart

24-May-20 -- 23-May-22

Price ($)

Sentiment

Company Sentiment

Most Recent Insider Transactions